SCHEMBL8749894

SCHEMBL8749894

CCC(Nc1nc(N)c2ncn([C@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1)c1ccccc1

nearest known ligand 0.76

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.74
ADORA3 P0DMS8 1/20 0.74
CYP1A2 P05177 2/20 0.71
ADORA2B P29275 2/20 0.71
THPO P40225 1/20 0.71
MEN1 O00255 1/20 0.71
CYP2D6 P10635 1/20 0.71
CYP2C9 P11712 1/20 0.71
CYP2C19 P33261 1/20 0.71
KMT2A Q03164 1/20 0.71
BLM P54132 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8749991 1.00 ADORA2A (0.74) ADORA2AADORA3CYP1A2ADORA2BTHPO
SCHEMBL8749885 1.00 ADORA2A (0.74) ADORA2AADORA3CYP1A2ADORA2BTHPO
SCHEMBL8749881 1.00 ADORA2A (0.74) ADORA2AADORA3CYP1A2ADORA2BTHPO
SCHEMBL8749873 1.00 ADORA2A (0.74) ADORA2AADORA3CYP1A2ADORA2BTHPO
SCHEMBL10587420 0.88 ADORA2A (0.74) ADORA2AADORA3CYP1A2ADORA2BTHPO
SCHEMBL10588149 0.86 CYP1A2 (0.75) ADORA2ACYP1A2ADORA2BTHPOMEN1
SCHEMBL10588145 0.86 CYP1A2 (0.75) ADORA2ACYP1A2ADORA2BTHPOMEN1
SCHEMBL13084518 0.86 ADORA2A (0.77) ADORA2AADORA3CYP1A2ADORA2BTHPO
SCHEMBL9761625 0.85 ADORA2A (0.70) ADORA2AADORA3CYP1A2ADORA2BTHPO
SCHEMBL8110565 0.85 ADORA2A (1.00) ADORA2AADORA3CYP1A2ADORA2BTHPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0662975-B1 2-SUBSTITUTED ADENOSINES WITH A-2 RECEPTOR AFFINITY MERRELL PHARMA INC (US) 1997-03-26 EP disclosed
US-5426101-A Hypotensive agents MERRELL DOW PHARMACEUTICALS INC. (US) 1995-06-20 US disclosed